GCN2 Polyclonal Antibody

EIF2AK4 encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the down regulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2.

The GCN2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of GCN2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity. With its exceptional performance, this antibody enables accurate and precise identification of GCN2 protein in Western blotting, immunohistochemistry, and immunofluorescence applications.

The GCN2 Polyclonal Antibody exhibits excellent specificity, exhibiting minimal cross-reactivity with other proteins, thus providing reliable and reproducible results. Its robust performance allows for the detection of GCN2 protein in a wide range of species, including human, mouse, and rat.

This antibody is supplied as a liquid formulation, making it convenient and easy to use. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The GCN2 Polyclonal Antibody is compatible with various experimental conditions and can be used in both research and clinical settings.

With its exceptional quality and performance, the GCN2 Polyclonal Antibody is an indispensable tool for researchers and scientists studying the GCN2 protein and its role in cellular processes. Its reliable and accurate results make it an ideal choice for a wide range of applications, including protein expression analysis, biomarker discovery, and drug development.